Market Overview

BioForward Announces Winners of Fourth Annual Wisconsin Biohealth Awards

Share:

BioForward has announced the winners of the annual Wisconsin Biohealth
Awards, dedicated to showcasing leadership and innovation in the
Wisconsin biohealth industry. The 2018 winners of the Hector F. DeLuca
Scientific Achievement Award and Wisconsin Biohealth Business
Achievement Award include Dr. Allen W. Cowley, Jr. and Kevin Conroy,
respectively.

Dr. Allen W. Cowley, Jr., is a professor and chair of the
department of Physiology at the Medical College of Wisconsin (MCW). Dr.
Cowley is an international leader in cardiovascular research and has
made seminal observations that have advanced understanding of
hypertension. As the chair of Physiology, Dr. Cowley forged the
development and integration of genomics, bioinformatics, computational
biology and physiology to address questions of clinical importance. He
spearheaded efforts which resulted in the investment of more than $100
million for the development of the needed infrastructure to link genes
to complex physiological functions and diseases. Dr. Cowley has received
many awards and honors recognizing his work, including MCW's
Distinguished Service Award, multiple honorary doctorates, and awards
from the American Physiological Society and the American Heart
Association.

Kevin Conroy is chairman and chief executive officer of Exact
Sciences Corporation. Exact Sciences is focused on the early detection
and prevention of cancer, establishing a new standard for colon cancer
screening with its noninvasive, advanced DNA screening test, Cologuard.
Before joining Exact Sciences, Mr. Conroy served as president and chief
executive officer of Third Wave Technologies, a molecular diagnostics
company, until the company's acquisition by Hologic, Inc. Previously, he
served as intellectual property counsel at GE Healthcare and in private
practice.

"These awards are a testament to the dedication and innovation both Dr.
Allen Cowley and Kevin Conroy have put forth in Wisconsin's biohealth
industry," said Lisa Johnson, CEO of BioForward. "We're honored to
recognize two individuals who have made a significant impact on both
global human health and Wisconsin's economy."

The Wisconsin Biohealth Awards were launched in 2015, recognizing
scientific and business successes that have brought Wisconsin to be
among the top leaders in integrated health solutions. Past awardees
include Dr. Lynn-Allen Hoffman of Stratatech-Mallinckrodt, Cynthia
LaConte of The Dohmen Company, Dr. James Thompson of UW-Madison, Ralph
Kauten of Lucigen, Dr. Hector DeLuca of UW-Madison and Deltanoid
Pharmaceuticals, and Bill Linton of Promega.

Dr. Allen W. Cowley, Jr. and Kevin Conroy will be honored during a lunch
ceremony at the Wisconsin Biohealth Summit presented by BioForward on
October 9, 2018, at the Overture Center in Madison, Wisconsin.
Additional information on the Wisconsin Biohealth Awards, awardees, and
the Wisconsin Biohealth Summit can be found at www.wisconsinbiohealthsummit.org.

About BioForward

BioForward serves as the independent voice of Wisconsin's biohealth
industry, providing services and resources to support the growth of our
industry throughout the U.S. and the world. BioForward is the only
Wisconsin organization representing over 200 biohealth member companies
including biotech, biopharma, medical device, diagnostics, digital
health, as well as research institutions, and service providers. Learn
more about BioForward Wisconsin and their initiatives for 2018 at www.bioforward.org.

About Medical College of Wisconsin

With a history dating back to 1893, The Medical College of Wisconsin is
dedicated to leadership and excellence in education, patient care,
research and community engagement. More than 1,200 students are enrolled
in MCW's medical school and graduate school programs in Milwaukee, Green
Bay, and Central Wisconsin. MCW's School of Pharmacy opened in 2017. A
major national research center, MCW is the largest research institution
in the Milwaukee metro area and second largest in Wisconsin. In FY2016,
faculty received more than $184 million in external support for
research, teaching, training and related purposes. This total includes
highly competitive research and training awards from the National
Institutes of Health (NIH). Annually, MCW faculty direct or collaborate
on more than 3,100 research studies, including clinical trials.
Additionally, more than 1,500 physicians provide care in virtually every
specialty of medicine for more than 525,000 patients annually.

About Exact Sciences

Exact Sciences Corp. is a molecular diagnostics company focused on the
early detection and prevention of the deadliest forms of cancer. The
company has exclusive intellectual property protecting its non-invasive,
molecular screening technology for the detection of colorectal cancer.
For more information, please visit the company's website at www.exactsciences.com,
follow Exact Sciences on Twitter @ExactSciences or find Exact Sciences
on Facebook.

View Comments and Join the Discussion!